表紙
市場調査レポート

世界の獣医医療市場:成長、動向、予測

Global Veterinary Healthcare Market - Growth, Trends and Forecasts (2015 - 2020)

発行 Mordor Intelligence LLP 商品コード 319379
出版日 ページ情報 英文
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=102.12円で換算しております。
Back to Top
世界の獣医医療市場:成長、動向、予測 Global Veterinary Healthcare Market - Growth, Trends and Forecasts (2015 - 2020)
出版日: 2016年01月01日 ページ情報: 英文
概要

世界の獣医医療市場は、2014年に248億米ドル規模となりました。同市場は2019年にかけCAGR7.86%で拡大し、世界的な需要は2019年までに343億9,000万米ドルに達すると予測されています。

当レポートでは、世界の獣医医療市場の現状と将来予測、セグメント別、地域別動向とともに、主要な参入企業の競合環境とプロファイルなどをまとめています。

第1章 イントロダクション

第2章 市場分析

  • 動物医療製品
  • バリューチェーン分析
  • 動物医療と人間医療

第3章 市場動向

  • 市場促進因子
    • ペットオーナーシップ
    • 栄養の改善
    • 消費者が食品の安全性への注意を高めている
    • 飼料の増産
    • 動物原性感染病および食物経由の疾患
  • 市場阻害因子
    • 耕作地と水の危機
    • 耕作地の競争激化
    • 費用対効果の高い生産
  • ポーターズファイブフォース分析

第4章 市場セグメンテーション:世界の動物医療

  • 市場セグメンテーション:動物に基づく製品の種類
  • 動物診断薬
  • 遺伝子学
  • 種別市場セグメンテーション
  • 地域別市場セグメンテーション
    • アジア太平洋地域
    • 欧州
    • 北米
    • ラテンアメリカ

第5章 競合環境

  • 市場における主要企業
  • 市場シェア分析
  • 合併・買収
  • 新製品上市
  • 協定、連携、パートナーシップ

第6章 市場におけるトップ企業

  • Zoetis Animal Healthcare
  • Merck Ltd.
  • Merial ( Animal Health division of Sanofi)
  • Elanco Animal Health
  • Bayer Animal Health
  • Novartis Animal Health
  • Virbac Animal Health
  • Boehringer Ingelheim

第7章 付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

The Global veterinary healthcare market, estimated at $23.1 Billion in 2015, is set to reach $34.04 Billion by 2020, with a CAGR of 8.06% over the forecast period. Veterinary healthcare market is gaining importance as a result of manufacturers focus on production of products with specialized formulations and specialized manufacturing processes.

The importance of livestock animals is generating growth in the animal healthcare market because of more people consuming meat and dairy products. Population boom, stable economy is expected to result in increased demand for protein rich foods, especially in developing regions. Animal health companies are well positioned to address this growing emerging market demand for higher-protein diets.

In United States alone, Americans spent more than $53 billion on food, pet supplies, over-the-counter and prescription medications, veterinary care, live animal purchases, and other pet-related services. Increased love for the pets leading to increased ownership, more people awareness for animal health, and far less requirements for animal health drugs approval are the major driving factors for the market. Another factor that drives the market is continuous innovations and technological advances in development of animal health drugs. However, increased competition for cultivated land and scarcity of arable land are the major restraints for the market growth.

The new type of diseases in animals and their subsequent transfer to humans via animal food product consumption and companionship are escalating the veterinary healthcare industry globally. The strategic decisions in research and development of manufacturers are expected to positively impact global veterinary healthcare market.

In this report, global veterinary healthcare market is discussed in detail with segmentation by animal products (vaccines, paraciticides, anti-infectives, medicinal feed additives and other pharmaceuticals), animal types (companion animals, farm animals), animal diagnostic market and animal genetics market. Companion animals contribute 44.3% and farm animals 55.7 % to the global animal market. Geographically market is segmented into North America, Europe, Asia-Pacific, Latin America and ROW (Rest of world).

Europe is the leading market in animal healthcare followed by North America because of more consumption of meat and dairy products. Italy has the highest market share of 42.8 % in Europe region followed by UK with 30.2%. Asia-pacific and other developing regions hold a major revenue pocket in this market. Countries such as India, China and Brazil will be the major contributors to the market.

Major companies discussed in this report are Zoetis animal health, Merck, Merial (Animal Health division of Sanofi), Elanco Animal Health, Bayer Animal Health, Ceva Animal Health, Virbac Animal Health and Boehringer Ingelheim.

What makes our report unique?

  • 1) In-depth analysis of current market trends and future forecasts of the market based on different products available for both companion and farm animals.
  • 2) We provide longest possible market segmentation of the market based on products available, type of species, and geography. We give you the competitive landscape for the market which provides information about major players in the market, their respective market shares and recent developments.
  • 3) High-level analysis on vaccines, anti-infectives, medicinal feed additives, paraciticides, as well as novel products such as DNA and recombinant vaccines.

Table of Contents

  • Introduction
  • Study deliverables
  • Market Definition
  • Sizing Units
  • Base Currency
  • Review and Forecast period years
  • General Study Assumptions
  • Research Methodology
  • Introduction
  • Analysis Methodology
  • Econometric Forecast Model
  • Research Assumptions
  • Executive Summary
  • Key Inferences
  • Market Overview and Industry trends
  • Current Market Scenario
  • Technology Overview
  • New Developments
  • Industry Value chain analysis
  • Product Life cycle analysis
  • Product Benchmarking
  • Investment Analysis
  • Porter's Five Forces
  • Bargaining Power of Suppliers
  • Bargaining Power of Consumers
  • Threat to new entrants
  • Threat to substitute products and services
  • Competitive Rivalry within the industry
  • Drivers, Restraints, Opportunities, and challenges Analysis
  • Market Drivers
  • Pet Ownership
  • Improved Nutrition
  • Intensifying Consumer Focus on food safety
  • Greater Livestock Production
  • Increasing Zoonotic and Foodborne diseases
  • Market Restraints
  • Scarcity of arable land and water
  • Increased competition for cultivated land
  • Cost effective production
  • Opportunities
  • Threats
  • Global Veterinary Healthcare- Market Segmentation
  • By type of Products based on Animals
  • Companion Animals
  • Vaccines
  • Paraciticides
  • Anti-Infectives
  • Medicinal Feed additives
  • Other Pharmaceuticals
  • Farm Animals
  • Anti-Infective
  • Calcium Supplement
  • Hormone
  • Infusion
  • Mineral Supplement
  • NSAID
  • Paraciticides
  • Rumenotoric
  • Supportive
  • Vitamin Supplement
  • Poultry
  • Anti-infectives
  • Disinfectants
  • Feed Additives
  • MFA( Medicated Feed Additives)
  • Nutritionals
  • Vaccines
  • Animal Diagnostics
  • Enzyme Linked Immuno Sorbent Assay (ELISA)
  • Rapid Immuno Migration (RIM)
  • Agar Gel Immuno Diffusion (AGID)
  • Genetics
  • HD 50K for Angus
  • CLARIFIDE® for Dairy
  • Sheep 50K
  • CLARIFIDE® for Nelore
  • By Species
  • Farm animal
  • Cattle
  • Swine
  • Poultry
  • Fish
  • Sheep
  • Companion Animals
  • Dogs
  • Cats
  • Horses
  • Global Veterinary market by Geography - Regional shares and forecast
  • North America
  • Introduction
  • USA
  • Canada
  • Mexico
  • Rest of North America
  • Europe
  • Introduction
  • France
  • UK
  • Germany
  • Spain and Portugal
  • Italy
  • Rest of Europe
  • Asia-Pacific
  • Introduction
  • India
  • China
  • Japan
  • South Korea
  • Australia and New Zealand
  • Rest of Asia Pacific
  • Middle East and Africa
  • Introduction
  • GCC
  • Egypt
  • Rest of Middle East and Africa
  • Latin America
  • Introduction
  • Brazil
  • Argentina
  • Rest of Latin America
  • Competitive Landscape
  • Merger and acquisition analysis
  • New Product Launches
  • Agreements, Collaborations and Parterships
  • Key Vendor Analysis
  • Zoetis Animal Healthcare
  • Merck Ltd
  • Merial (Animal Health division of Sanofi)
  • Elanco Animal Health
  • Bayer Animal Health
  • Ceva Animal Health
  • Virbac Animal Health
  • Boehringer Ingelheim
  • Analyst outlook for Investment opportunities

4. Future Outlook of the market

  • 4.1. Market Segmentaion- By type of Products based on Animals
    • 4.1.1. Companion Animals
      • 4.1.1.1. Vaccines
      • 4.1.1.2. Paraciticides
      • 4.1.1.3. Anti-Infectives
      • 4.1.1.4. Medicinal Feed additives
      • 4.1.1.5. Other Pharmaceuticals
    • 4.1.2. Farm Animals
      • 4.1.2.1. Anti-Infective
      • 4.1.2.2. Calcium Supplement
      • 4.1.2.3. Hormone
      • 4.1.2.4. Infusion
      • 4.1.2.5. Mineral Supplement
      • 4.1.2.6. NSAID
      • 4.1.2.7. Paraciticides
      • 4.1.2.8. Rumenotoric
      • 4.1.2.9. Supportive
      • 4.1.2.10. Vitamin Supplement
    • 4.1.3. Poultry
      • 4.1.3.1. Anti-infectives
      • 4.1.3.2. Disinfectants
      • 4.1.3.3. Feed Additives
      • 4.1.3.4. MFA( Medicated Feed Additives)
      • 4.1.3.5. Nutritionals
      • 4.1.3.6. Vaccines
  • 4.2. Animal Diagnostics
    • 4.2.1. Enzyme Linked Immuno Sorbent Assay (ELISA)
    • 4.2.2. Rapid Immuno Migration (RIM)
    • 4.2.3. Agar Gel Immuno Diffusion (AGID)
  • 4.3. Genetics
    • 4.3.1. HD 50K for Angus
    • 4.3.2. CLARIFIDE® for Dairy
    • 4.3.3. Sheep 50K
    • 4.3.4. CLARIFIDE® for Nelore
  • 4.4. Market Segmentation, By Species
    • 4.4.1. Farm animal
      • 4.4.1.1. Cattle
      • 4.4.1.2. Swine
      • 4.4.1.3. Poultry
      • 4.4.1.4. Fish
      • 4.4.1.5. Sheep
    • 4.4.2. Companion Animals
      • 4.4.2.1. Dogs
      • 4.4.2.2. Cats
      • 4.4.2.3. Horses
  • 4.5. Market Segmentation, By Geography
    • 4.5.1. Asia Pacific
      • 4.5.1.1. China
      • 4.5.1.2. India
      • 4.5.1.3. Australia
      • 4.5.1.4. Japan
    • 4.5.2. Europe
      • 4.5.2.1. France
      • 4.5.2.2. Germany
      • 4.5.2.3. UK
      • 4.5.2.4. Spain
      • 4.3.2.5. Denmark
    • 4.5.3. North America
      • 4.5.3.1. US
    • 4.5.4. Latin America
      • 4.5.4.1. Brazil

5. Competitive landscape

  • 5.1. Major Players in Market
  • 5.2. New Product Launches
  • 5.3. Mergers and Acquisitions
  • 5.4. Agreements, Collaborations and Partnerships

6. Top Players in the Market

  • 6.1. Zoetis Animal Healthcare
    • 6.1.1. Financial Overview
    • 6.1.2. Business Overview
    • 6.1.3. Business Strategies
  • 6.2. Merck Ltd.
    • 6.2.1. Financial Overview
    • 6.2.2. Business Overview
    • 6.2.3. Business Strategies
  • 6.3. Merial ( Animal Health division of Sanofi)
    • 6.3.1. Financial Overview
    • 6.3.2. Business Overview
    • 6.3.3. Business Strategies
  • 6.4. Elanco Animal Health
    • 6.4.1. Financial Overview
    • 6.4.2. Business Overview
    • 6.4.3. Business Strategies
  • 6.5. Bayer Animal Health
    • 6.5.1. Financial Overview
    • 6.5.2. Business Overview
    • 6.5.3. Business Strategies
  • 6.6. Ceva Animal Health
    • 6.6.1. Financial Overview
    • 6.6.2. Business Overview
    • 6.6.3. Business Strategies
  • 6.7. Virbac Animal Health
    • 6.7.1. Financial Overview
    • 6.7.2. Business Overview
    • 6.7.3. Business Strategies
  • 6.8. Boehringer Ingelheim
    • 6.8.1. Financial Overview
    • 6.8.2. Business Overview
    • 6.8.3. Business Strategies

7. Appendix

  • 7.1. Abbreviations
  • 7.2. Sources
  • 7.3. Bibliography
  • 7.4. Disclaimer
Back to Top